Publications by authors named "Hayley Noble"

Article Synopsis
  • Functional motor disorder, a type of neurological issue, can lead to significant health problems and new treatment methods like specialized physiotherapy have been developed, though large scale studies are limited.
  • A phase 3 randomized controlled trial was conducted across 11 hospitals in England and Scotland, where participants were assigned to either specialized physiotherapy or standard care to assess the effectiveness of the intervention on physical functioning after 12 months.
  • The trial included 355 participants, with recruitment affected by the COVID-19 pandemic, and aimed to provide evidence on whether specialized physiotherapy leads to better outcomes compared to conventional treatment.
View Article and Find Full Text PDF

Introduction: Functional motor disorder (FMD) is a common cause of disabling neurological symptoms such as weakness and tremor. Physio4FMD is a pragmatic, multicentre single blind randomised controlled trial to evaluate effectiveness and cost effectiveness of specialist physiotherapy for FMD. Like many other studies this trial was affected by the COVID-19 pandemic.

View Article and Find Full Text PDF

Background: Patients with functional motor disorder (FMD) experience persistent and disabling neurological symptoms such as weakness, tremor, dystonia and disordered gait. Physiotherapy is usually considered an important part of treatment; however, sufficiently-powered controlled studies are lacking. Here we present the protocol of a randomised controlled trial (RCT) that aims to evaluate the clinical and cost effectiveness of a specialist physiotherapy programme for FMD.

View Article and Find Full Text PDF

Background: The study investigated the feasibility of conducting a future Randomised Controlled Trial (RCT) of a mobile health (mHealth) intervention for weight loss and HbA1c reduction in Type 2 Diabetes Mellitus (T2DM).

Methods: The intervention was a small wearable mHealth device used over 12 weeks by overweight people with T2DM with the intent to lose weight and reduce their HbA1c level. A 4 week maintenance period using the device followed.

View Article and Find Full Text PDF